From Passion Health Primary Care – Clinically Accurate, Regionally & Globally Informed
Today’s health update delivers critical headlines: the FDA allows Sarepta to resume shipments of Elevidys gene therapy for Duchenne patients, a Senate probe investigates vaccine advisory panel dismissals, and AstraZeneca sees strong Q2 growth. Closer to home, Texas health concerns escalate with sustained flood fatalities and a growing measles outbreak. Globally, Portugal battles climate-driven wildfires affecting public health. At Passion Health, we emphasize timely, evidence-based care—from chronic disease management to vaccine guidance and environmental health response.
🇺🇸 National Updates
✅ Sarepta Resumes U.S. Shipments of Elevidys Gene Therapy
Sarepta shares rose ~30% as the FDA lifted its voluntary pause on Elevidys shipments for ambulatory Duchenne muscular dystrophy patients—though use remains suspended for non‑ambulatory pediatric cases .
✅ Entities Launch Senate Probe of ACIP Dismissals
Senate Democrats opened an investigation into HHS Secretary Kennedy’s removal of the CDC’s vaccine advisory panel, citing public health risks if scientifically grounded vaccine access declines.
✅ AstraZeneca Posts Strong Q2 on New Drug Demand
Robust U.S. sales in cancer, cardiovascular, and renal medications drove AstraZeneca’s
Q2 earnings above expectations despite global tariff concerns .
🏥 Texas Updates
✅ Fatal Flood Count Holds at 137; State Probes Continue
Central Texas flood deaths remain at 137. State legislators are reviewing emergency response gaps including delayed warnings and funding shortfalls.
✅ Measles Surges in Texas; Wastewater Signals Rebound Risk
Texas remains the measles epicenter with ~790 confirmed cases; wastewater signals in Austin raise concerns of resurgence before school season.
🌍 Global Health Alerts
✅ Record Wildfires in Portugal Underline Climate Risks
Over 1,300 firefighters battle multiple wildfires in northern Portugal as Europe endures extreme summer heat—evacuations and smoke exposures pose acute health risks .
💡 Clinical Tips for Providers
• Counsel eligible Duchenne patients on resumed Elevidys access and updated safety guidance.
• Reinforce vaccine advocacy amid panel controversy and measles resurgence.
• Monitor heat-related symptoms and air quality effects, especially in travelers returning from wildfire-impacted areas.
